Trials / Completed
CompletedNCT02803216
Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori
Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori: a Prospective, Double-blinded, Randomized Trial
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 576 (actual)
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of Traditional Chinese Medicine (TCM) decoction and powder combined with standard triple therapy on improving eradication rate of Helicobacter Pylori (H. pylori).A multi-center randomized control clinical trial design was adopted in the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | standard triple region | ten days of standard triple region (20mg omeprazole 20mg, 1.0 amoxicillin, 0.5 clarithromycin, Bid). |
| DRUG | 2-week Xiang-sha-liu-jun decoction | 2-week Xiang-sha-liu-jun decoction, bid. |
| DRUG | 4-week Xiang-sha-liu-jun decoction | 4-week Xiang-sha-liu-jun decoction, bid. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-12-01
- Completion
- 2016-04-01
- First posted
- 2016-06-16
- Last updated
- 2016-09-05
Source: ClinicalTrials.gov record NCT02803216. Inclusion in this directory is not an endorsement.